Government of Quebec provides adults living with diabetes mellitus access to ultra-long-acting insulin, TRESIBA®

Novo Nordisk Canada Inc. announces that Quebec will provide public funding of TRESIBA® (insulin degludec injection), an ultra-long-acting basal insulin, for adults living with Type 1 and Type 2 diabetes. Listed under the List of Medications reimbursed un